"The surprising failure of a large clinical trial of H.I.V.-prevention methods in Africa — and the elaborate deceptions employed by the women in it — have opened an ethical debate about how to run such studies in poor countries and have already changed the design of some that are now underway."
Ethically-tangled aspects of 21st century societies and cultures. In the vein of Charles Darwin’s 1859 “entangled bank” metaphor—a complex and evolving digital ecosystem of difference and dependence, where humans, technologies, ethics, law, policy, data, and information converge and diverge. Kip Currier, PhD, JD
Showing posts with label clinical trial of H.I.V.-prevention methods in Africa. Show all posts
Showing posts with label clinical trial of H.I.V.-prevention methods in Africa. Show all posts
Thursday, February 5, 2015
A Failed Trial in Africa Raises Questions About How to Test H.I.V. Drugs; New York Times, 2/4/15
Donald G. McNeil Jr., New York Times; A Failed Trial in Africa Raises Questions About How to Test H.I.V. Drugs:
Subscribe to:
Posts (Atom)